{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T23:41:21Z","timestamp":1680133281292},"reference-count":20,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1055\/a-1873-4786","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T23:18:58Z","timestamp":1680131938000},"page":"459-466","source":"Crossref","is-referenced-by-count":0,"title":["Transplantation\/Zelltherapie bei Akuter Myeloischer Leuk\u00e4mie"],"prefix":"10.1055","volume":"148","author":[{"given":"Alessia","family":"Fraccaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1200\/JCO.2011.39.6499","article-title":"Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories","volume":"30","author":"JJ Cornelissen","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"ED Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"JR Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3324\/haematol.2016.144139","article-title":"Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide","volume":"102","author":"SR McCurdy","year":"2017","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00277-019-03593-2","article-title":"Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis","volume":"98","author":"M Doppelhammer","year":"2019","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"J Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"H D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41375-019-0572-z","article-title":"Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality","volume":"34","author":"AJ Innes","year":"2020","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41375-019-0527-4","article-title":"Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT","volume":"34","author":"MH Gilleece","year":"2020","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/leu.2011.13","article-title":"Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia","volume":"25","author":"C Craddock","year":"2011","journal-title":"Leukemia"},{"key":"ref11","first-page":"1254","article-title":"Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission","volume":"96","author":"MS Tallman","year":"2000","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation","volume":"37","author":"M Frick","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"L Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/ajh.25281","article-title":"Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed\/refractory AML\/MDS","volume":"93","author":"A Fraccaroli","year":"2018","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","article-title":"Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"C Schmid","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","article-title":"Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party","volume":"25","author":"C Schmid","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41375-021-01148-x","article-title":"Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial","volume":"35","author":"C R\u00f6llig","year":"2021","journal-title":"Leukemia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1182\/blood-2007-02-072470","article-title":"Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia","volume":"109","author":"A Dominietto","year":"2007","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbmt.2012.12.013","article-title":"Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes","volume":"19","author":"P Krishnamurthy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00277-020-04321-x","article-title":"Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group","volume":"100","author":"E Schuler","year":"2021","journal-title":"Ann Hematol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1873-4786.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T23:20:05Z","timestamp":1680132005000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1873-4786"}},"subtitle":["Wer, Wann, Warum und Wie?"],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":20,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1873-4786","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}